January 8, 2020

Drug Company’s Bankruptcy Announcement Highlights Urgent Need for Investment in Infection Fighting Drugs

The bankruptcy filing recently announced by antibiotic maker Melinta once again highlights the daunting challenges facing research and development of new infection-fighting drugs.

Congress Approves Funding for End the HIV Epidemic Initiative and Other Key HIV Programs

With the final passage of the FY 2020 spending bill, Congress took an important step in funding the administration’s Ending the HIV Epidemic initiative and some other high priority HIV programs but left other important programs under-funded.

Opportunity to Inform HIVMA’s Response to the Ending the HIV Epidemic Initiative

HIVMA is recruiting for a new working group to strengthen our response to the Ending the HIV Epidemic: A Plan for America initiative.

Journal Club

In this feature, a panel of IDSA members identifies and critiques important new studies in the current literature that have a significant impact on the practice of infectious diseases medicine.

Oritavancin for Gram-Positive Infections in the Real World: Hope or Hype? and Ninety-Six Week Data for Dolutegravir and Lamivudine in Adults with HIV

HIVMA Clinical Fellowship Program Application Deadline Extended

The HIVMA Clinical Fellowship Program is accepting applications for the 2020-2021 cycle. The program awards grants to support one year of HIV clinical training for up to two fellows per year.

Want to Become an Advocate for ID and HIV? Join the Advocacy Liaisons

IDSA and HIVMA are excited to open a call for volunteers for the newly created Advocacy Liaisons, a select group of member advocates charged with engaging more IDSA and HIVMA members in the regulatory and legislative process with the support of IDSA and HIVMA staff.

Science Speaks Looks Back on a Decade of Global ID Coverage

Launched in February 2009 to amplify the voices of physicians and scientists in guiding global health policy and practice, the IDSA/HIVMA Science Speaks blog covered breakthroughs and setbacks that changed approaches to preventing, detecting, and responding to infectious diseases worldwide over the decade that followed.

This is a Crisis that Should Alarm Everyone: Top Media Report on AMR

Antimicrobial resistance, one of IDSA’s top priorities, as well as the DISARM Act, IDSA-driven legislation to combat AMR, have been receiving significant media coverage in recent weeks – including high-profile articles in The New York Times and The Wall Street Journal.

Journal Club Archive